What is TalkMed Group Price-to-Operating-Cash-Flow?
As of today (2024-05-15), TalkMed Group's share price is S$0.395.
TalkMed Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was S$0.03. Hence, TalkMed Group's Price-to-Operating-Cash-Flow Ratio for today is 12.74.
The historical rank and industry rank for TalkMed Group's Price-to-Operating-Cash-Flow or its related term are showing as below:
SGX:5G3'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.67 Med: 18.13 Max: 30
Current: 12.74
During the past 12 years, TalkMed Group's highest Price-to-Operating-Cash-Flow Ratio was 30.00. The lowest was 2.67. And the median was 18.13.
TalkMed Group's Cash Flow from Operations per share for the
six
months ended in Dec. 2023 was S$0.02.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was S$0.03.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of TalkMed Group was 10.70% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 8.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -7.40% per year.
During the past 12 years, TalkMed Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 8.90% per year. The lowest was -97.90% per year. And the median was -8.45% per year.
TalkMed Group Price-to-Operating-Cash-Flow Historical Data
The historical data trend for TalkMed Group's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TalkMed Group Price-to-Operating-Cash-Flow Chart
|
TalkMed Group Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
19.26 |
18.13 |
22.94 |
14.29 |
12.26 |
|
TalkMed Group Semi-Annual Data
|
|
Jun14 |
Dec14 |
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
22.94 |
- |
14.29 |
- |
12.26 |
Competitive Comparison of TalkMed Group's Price-to-Operating-Cash-Flow
For the Medical Care Facilities subindustry, TalkMed Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TalkMed Group's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where TalkMed Group's Price-to-Operating-Cash-Flow falls into.
TalkMed Group Price-to-Operating-Cash-Flow Calculation
TalkMed Group's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.395 | / | 0.031 |
| = | 12.74 |
TalkMed Group's Share Price of today is S$0.395.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TalkMed Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was S$0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
TalkMed Group (SGX:5G3) Business Description
Traded in Other Exchanges
N/A
Address
3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510
TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.
TalkMed Group (SGX:5G3) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGX:5G3 has been successfully added to your